All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC1370 | Human anti-WDR46 T cell receptor (AC3), pCDTCR1 | Human | AC3 | Human | FLTYLDVSV | HLA-A2 | Lentiviral vector | |
TCR-YC1371 | Human anti-WDR46 T cell receptor (AC7), pCDTCR1 | AC7 | Human | FLIYLDVSV | HLA-A2 | Lentiviral vector | ||
TCR-YC1372 | Human anti-WDR46 T cell receptor (BC12), pCDTCR1 | Human | BC12 | Human | FLTYLDVSV | HLA-A2 | Lentiviral vector | |
TCR-YC1373 | Human anti-WDR46 T cell receptor (BD6), pCDTCR1 | Human | BD6 | Human | FLTYLDVSV | HLA-A2 | Lentiviral vector | |
TCR-YC1374 | Human anti-WDR46 T cell receptor (BG3), pCDTCR1 | Human | BG3 | Human | FLTYLDVSV | HLA-A2 | Lentiviral vector | |
TCR-YC1375 | Human anti-WDR46 T cell receptor (BG8), pCDTCR1 | Human | BG8 | Human | FLTYLDVSV | HLA-A2 | Lentiviral vector | |
TCR-YC1376 | Human anti-WDR46 T cell receptor (CC5), pCDTCR1 | Human | CC5 | Human | FLTYLDVSV | HLA-A2 | Lentiviral vector | |
TCR-YC1377 | Human anti-WDR46 T cell receptor (CF2), pCDTCR1 | CF2 | Human | FLIYLDVSV | HLA-A2 | Lentiviral vector | ||
TCR-YC1378 | Human anti-WDR46 T cell receptor (E11), pCDTCR1 | E11 | Human | FLIYLDVSV | HLA-A2 | Lentiviral vector | ||
TCR-YC1379 | Human anti-WDR46 T cell receptor (FD8), pCDTCR1 | FD8 | Human | FLIYLDVSV | HLA-A2 | Lentiviral vector | ||
TCR-YC1380 | Human anti-WDR46 T cell receptor (FF11), pCDTCR1 | FF11 | Human | FLIYLDVSV | HLA-A2 | Lentiviral vector | ||
TCR-YC1381 | Human anti-WDR46 T cell receptor (G21), pCDTCR1 | Human | G21 | Human | FLTYLDVSV | HLA-A2 | Lentiviral vector | |
TCR-YC1382 | Human anti-WDR46 T cell receptor (IA1), pCDTCR1 | IA1 | Human | FLIYLDVSV | HLA-A2 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION